Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Body
Daniela Niepel
Giuseppe Tonini

Showing results (1-10 of 557) with videos related to

Pageof 56
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2017
Hypercalcaemia and hypocalcaemia: finding the balanceJean-Jacques Body, Daniela Niepel, Giuseppe Tonini
BMC Urology|September 22, 2018
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completionJean-Jacques Body, Roger von Moos, Daniela Niepel, et al.
Cancer Treatment Reviews|May 29, 2019
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibodyRoger von Moos, Luis Costa, Eva Gonzalez-Suarez, et al.
Current Opinion in Oncology|April 27, 2011
New developments for treatment and prevention of bone metastasesJean-Jacques Body
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Breast cancer: bisphosphonate therapy for metastatic bone diseaseJean-Jacques Body
The Oncologist|April 27, 2005
Bisphosphonate safety and tolerabilityJean-Jacques Body
Breast (Edinburgh, Scotland)|December 9, 2003
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesionsJean-Jacques Body
Cancer|January 28, 2003
Effectiveness and cost of bisphosphonate therapy in tumor bone diseaseJean-Jacques Body
La Revue Du Praticien|March 11, 2004
[How to treat tumor-induced hypercalcemia]Jean-Jacques Body
Supportive Cancer Therapy|July 18, 2008
The risk of cumulative renal effects of intravenous bisphosphonatesJean-Jacques Body
Pageof 56

Showing results (1-10 of 557) with videos related to

Sort By:
Pageof 56
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2017
Hypercalcaemia and hypocalcaemia: finding the balanceJean-Jacques Body, Daniela Niepel, Giuseppe Tonini
BMC Urology|September 22, 2018
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completionJean-Jacques Body, Roger von Moos, Daniela Niepel, et al.
Cancer Treatment Reviews|May 29, 2019
Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibodyRoger von Moos, Luis Costa, Eva Gonzalez-Suarez, et al.
Current Opinion in Oncology|April 27, 2011
New developments for treatment and prevention of bone metastasesJean-Jacques Body
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Breast cancer: bisphosphonate therapy for metastatic bone diseaseJean-Jacques Body
The Oncologist|April 27, 2005
Bisphosphonate safety and tolerabilityJean-Jacques Body
Breast (Edinburgh, Scotland)|December 9, 2003
Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesionsJean-Jacques Body
Cancer|January 28, 2003
Effectiveness and cost of bisphosphonate therapy in tumor bone diseaseJean-Jacques Body
La Revue Du Praticien|March 11, 2004
[How to treat tumor-induced hypercalcemia]Jean-Jacques Body
Supportive Cancer Therapy|July 18, 2008
The risk of cumulative renal effects of intravenous bisphosphonatesJean-Jacques Body
Pageof 56